These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 34790819)
21. Identification of a novel prognostic signature composed of 3 cuproptosis-related transcription factors in colon adenocarcinoma. Zhou L; Zhang Y; Xu Y; Jiang T; Tang L Genes Genomics; 2023 Aug; 45(8):1047-1061. PubMed ID: 37318704 [TBL] [Abstract][Full Text] [Related]
22. Establishment of a novel prognostic signature based on an identified expression profile of integrin superfamily to predict overall survival of patients with colorectal adenocarcinoma. Yu J; Yang K; Zheng J; Sun X; Zhao W Gene; 2022 Jan; 808():145990. PubMed ID: 34624456 [TBL] [Abstract][Full Text] [Related]
23. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma. Tan Y; Lu L; Liang X; Chen Y World J Surg Oncol; 2022 Apr; 20(1):118. PubMed ID: 35413978 [TBL] [Abstract][Full Text] [Related]
24. Comprehensive analysis of the immune implication of FABP4 in colon adenocarcinoma. Wu D; Xiang L; Peng L; Gu H; Tang Y; Luo H; Liu H; Wang Y PLoS One; 2022; 17(10):e0276430. PubMed ID: 36264920 [TBL] [Abstract][Full Text] [Related]
25. Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma. Xiao J; Wang X; Liu Y; Liu X; Yi J; Hu J Front Immunol; 2022; 13():881359. PubMed ID: 35911752 [TBL] [Abstract][Full Text] [Related]
26. Construction of a prognostic risk model based on pyroptosis-related genes and comprehensive analysis of key genes and tumor immune microenvironment for colon cancer. Liu M; Zhang J; Zhao Y; Zhang X Medicine (Baltimore); 2024 Sep; 103(36):e39300. PubMed ID: 39252305 [TBL] [Abstract][Full Text] [Related]
27. Prediction and identification of immune genes related to the prognosis of patients with colon adenocarcinoma and its mechanisms. Chen S; Cao GD; Wei W; Yida L; Xiaobo H; Lei Y; Ke C; Chen B; Xiong MM World J Surg Oncol; 2020 Jun; 18(1):146. PubMed ID: 32600423 [TBL] [Abstract][Full Text] [Related]
28. Glucose metabolism-based signature predicts prognosis and immunotherapy strategies for colon adenocarcinoma. Bai Z; Yan C; Nie Y; Zeng Q; Xu L; Wang S; Chang D J Gene Med; 2024 Jan; 26(1):e3620. PubMed ID: 37973153 [TBL] [Abstract][Full Text] [Related]
29. Development and Validation of a Prognostic Model based on 11 E3-related Genes for Colon Cancer Patients. JIang W; Dong J; Zhang W; Huang Z; Guo T; Zhang K; Jiang X; Du T Curr Pharm Des; 2024; 30(12):935-951. PubMed ID: 38898815 [TBL] [Abstract][Full Text] [Related]
30. Mining novel cell glycolysis related gene markers that can predict the survival of colon adenocarcinoma patients. Chen S; Cao G; Wu W; Lu Y; He X; Yang L; Chen K; Chen B; Xiong M Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32744303 [TBL] [Abstract][Full Text] [Related]
31. Identification of Molecular Subtypes and a Prognostic Signature Based on Inflammation-Related Genes in Colon Adenocarcinoma. Qiu C; Shi W; Wu H; Zou S; Li J; Wang D; Liu G; Song Z; Xu X; Hu J; Geng H Front Immunol; 2021; 12():769685. PubMed ID: 35003085 [TBL] [Abstract][Full Text] [Related]
32. Development and validation of a prognostic model for mitophagy-related genes in colon adenocarcinoma: A study based on TCGA and GEO databases. Tang Y; Guo H; Chen L; Wang X; Chen Q; Gou L; Liu X; Wang X PLoS One; 2023; 18(4):e0284089. PubMed ID: 37023088 [TBL] [Abstract][Full Text] [Related]
33. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma. Han C; Zhang C; Wang H; Li K; Zhao L BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056 [TBL] [Abstract][Full Text] [Related]
34. A Prognostic Model for Colon Adenocarcinoma Patients Based on Ten Amino Acid Metabolism Related Genes. Ren Y; He S; Feng S; Yang W Front Public Health; 2022; 10():916364. PubMed ID: 35712285 [TBL] [Abstract][Full Text] [Related]
35. A novel prognostic signature contributes to precision treatment in colon adenocarcinoma with KRAS mutation. Dong W; Zhang H; Li Q; Guan N; Yun C; Zhao H; Zhang F; Zeng Z; Hu Y; Li Q; Yang J; Ma Z; Chen M; Xiao W Eur J Cancer Prev; 2023 Nov; 32(6):557-565. PubMed ID: 37310401 [TBL] [Abstract][Full Text] [Related]
36. A novel enterocyte-related 4-gene signature for predicting prognosis in colon adenocarcinoma. Cheng X; Wei Y; Fu Y; Li J; Han L Front Immunol; 2022; 13():1052182. PubMed ID: 36532007 [TBL] [Abstract][Full Text] [Related]
37. Prognostic significance and immune landscape of a fatty acid metabolism-related gene signature in colon adenocarcinoma. Liu X; Fang X; Lu L; Liu G Front Genet; 2022; 13():996625. PubMed ID: 36568396 [No Abstract] [Full Text] [Related]
38. Identification of a novel glycolysis-related gene signature for predicting the survival of patients with colon adenocarcinoma. Yi K; Wu J; Tang X; Zhang Q; Wang B; Wang F Scand J Gastroenterol; 2022 Feb; 57(2):214-221. PubMed ID: 34644216 [TBL] [Abstract][Full Text] [Related]
39. An epithelial-mesenchymal transition-related mRNA signature associated with the prognosis, immune infiltration and therapeutic response of colon adenocarcinoma. Zhang Y; Li Y; Zuo Z; Li T; An Y; Zhang W Pathol Oncol Res; 2023; 29():1611016. PubMed ID: 36910014 [No Abstract] [Full Text] [Related]
40. Establishment of an immune-related gene pair model to predict colon adenocarcinoma prognosis. Luo J; Liu P; Wang L; Huang Y; Wang Y; Geng W; Chen D; Bai Y; Yang Z BMC Cancer; 2020 Nov; 20(1):1071. PubMed ID: 33167940 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]